RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 86 filers reported holding RELMADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHUMBLINE ADVISERS | 1,174 | $3,522 | 0.00% |
Squarepoint Ops LLC | 33,097 | $99,291 | 0.00% |
OSAIC HOLDINGS, INC. | 27 | $81 | 0.00% |
FMR LLC | 84,280 | $252,840 | 0.00% |
SEI INVESTMENTS CO | 36,230 | $108,690 | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 73,820 | $221,412 | 0.00% |
BANK OF AMERICA CORP /DE/ | 213,535 | $640,605 | 0.00% |
Russell Investments Group, Ltd. | 53 | $159 | 0.00% |
WELLS FARGO & COMPANY/MN | 530 | $1,590 | 0.00% |
NORTHERN TRUST CORP | 47,102 | $141,306 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 20,343 | $61,029 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 239,904 | $719,905 | 0.00% |
STATE STREET CORP | 115,229 | $345,687 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 244,201 | $732,603 | 0.00% |
PRICE T ROWE ASSOCIATES INC /MD/ | 159,290 | $478 | 0.00% |
TORONTO DOMINION BANK | 81 | $243 | 0.00% |
DEUTSCHE BANK AG\ | 4,959 | $14,877 | 0.00% |
Tower Research Capital LLC (TRC) | 1,710 | $5,130 | 0.00% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 12,505 | $37,515 | 0.00% |
External links
This page lists RELMADA THERAPEUTICS INC's shareholders in Q3 2023. To view RELMADA THERAPEUTICS INC's shareholder history, click here.